Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

IDEC and Roche submit applications for IDEC-C2B8

March 5, 1997

ONYX expands ONYX-015 clinical trials

March 4, 1997

Roche's Roferon-A receives EU approval

March 4, 1997

IGG's MMS-1 covered by patent

March 3, 1997

Immunotherapy cancer vaccine in phase II

Feb. 20, 1997

Encouraging results obtained for immunotoxin in Hodgkin's lymphoma

Feb. 17, 1997

Labeled SMART antibody shows promise for AML treatment

Feb. 17, 1997

Maxim's lead product approaches pivotal trials

Feb. 12, 1997

Genzyme Transgenics reports advances in transgenic production of MAbs

Feb. 11, 1997

Il Yang develops antitumor/immunostimulating proteoglycan

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...